Stock speculation is based on the Jin Kirin analyst Research report, authoritative, professional, timely and comprehensive, to help you tap potential theme opportunities.Crouchingtigerhiddendragonswordofdestinywangdulu!
Wen, Qi Yongchao
Today, there is a divergence in the market, which may make some investors who are just about to increase their positions lose their direction. However, foreign investors are still buying on a large scale, and the position dynamics of foreign investors may be able to provide some new investment ideas. Today, I would like to focus on talking about the "heart water stocks" of foreign investors, many of which have a good performance.
The index continues to consolidate
Reappearance of market "seesaw" effect
The establishment of the rebound of the index will never be achieved overnight, and it will generally go through a process of repeated confirmation, such as breaking through-stepping back-breaking again and so on. Therefore, in many cases, the adjustment of the index may be a good opportunity to "get on the train".
On May 8, the index showed a certain divergent correction. The Shanghai Composite Index performed relatively steadily, closing above the 5th line, while the Shenzhen Index failed to effectively break through the 9750-point first-line platform pressure level. After accumulating a certain increase in the previous trading days, there has been a technical rollback and repair requirements in the market.
However, in terms of the lengthening cycle, the index as a whole is in the band rebound channel. Measured from the low point, the Shanghai Composite Index has risen by more than 15% from February 6 to May 8; over the same period, the Shenzhen Composite Index has risen by more than 20%, and the gem has risen by nearly 20%.
From the perspective of plate performance, the "seesaw" effect of the market still exists, such as the style switch between today's high dividends and theme stocks. In fact, this phenomenon has been going on for a long time, when the market is under pressure, the performance of high dividends is strong, when the market is strong, high dividends stall, and subject stocks return to activity. To some extent, this also shows that the relay of incremental funds or the strength to enter the market is not strong enough.
At the same time, a number of core assets with relatively low stock prices and valuations continue to move, scrambling for funds, such as the Shanghai Stock Exchange 50 and the relevant targets of the Mao index. According to observation, many core assets have reached new highs, such as Guizhou Moutai, Shanxi Fenjiu, China Merchants Bank, Haier Zhijia, Sany heavy Industry and so on.
So, which direction of core assets should be focused on in 2024? You can scan the QR code below [free] to see the full content.
Foreign investment continues to increase.
Many "heart water stocks" are showing a strong performance.
Recently, while the index has established an upward inflection point, foreign investment has begun to attract a large amount of money.
At present, there are two main channels for foreign investment in A-shares, Lu Shitong and QFII. First, let's take a look at the Land Stock Exchange, which is represented by northward capital. The following set of data shows that on April 26th, the northward capital bought a net 22.4 billion yuan; on April 29th, it bought 10.9 billion yuan; and on May 6th, it bought a net 9.3 billion yuan. Compared with historical data, the continuous and large-scale purchases of northward funds indicate that there may be a big turning point in the market.
QFII is also adding code.
First, let's take a look at a group of overall data. As of the end of April, the quarterly report of A-share listed companies ended. QFII appears on the list of the top ten tradable shareholders of more than 700 stocks, with a cumulative market capitalization of more than 100 billion yuan. Among them, more than 500 stocks are new entrants or additional positions.
Most of QFII's heavy head layout targets are head core assets and related invisible champions in subdivided areas.
The following is an analysis of the two popular chemical and pharmaceutical tracks in the near future.
For a long time, the performance of the chemical sector has been lukewarm, but recently, the superposition of a number of event factors has completely made chemical stocks very popular. From a simple analysis, the stimulating factors may include, but are not limited to, the following For example, the strong cashing of performance, the price increase of related products, the optimization and adjustment of real estate-related policies to stimulate the related chemical materials stock changes, synthetic biology and other popular concepts drive the performance of related chemical stocks.
For the relevant chemical targets, QFII has already increased the layout.
For example, the Bill and Melinda Gates Foundation, which appeared on the list of the top 10 outstanding shareholders of three companies in the first quarter, increased its position in satellite chemical, the chemical target, by 101.Crouchingtigerhiddendragonswordofdestinywangdulu440,000 shares to 39.4369 million shares, and the 2023 annual report increased its positions by 6.608 million shares to 38.4225 million shares.
Satellite chemistry is mainly engaged in acrylic acid, downstream related to aerospace, new energy vehicles, electronic chips and other fields. Behind the increase of the Bill and Melinda Gates Foundation, satellite chemistry has also ushered in a good performance. The company's annual report last year and this year's quarterly report have ushered in double growth in performance. Judging from the performance of the secondary market, it has rebounded by more than 30% since January and 6% since the second quarter, setting a new high.
Let's talk about medicine. Recently, there has been a rise in the subdivision of medicine, such as immunotherapy, genetic concept, CXO (innovative drugs), weight loss drugs and so on.
Behind the changes in pharmaceutical stocks, there are not only the stimulation of industrial logic, but also the blessing of market, policy and other factors. For example, related vaccine research and development progress has made breakthroughs, synthetic biology driven, ASCO (American Society of Clinical Oncology) is about to be held, and cultivate the benefits related to the development of innovative drug industry. In addition, from a market point of view, pharmaceutical stocks have been under pressure for a long time, in which low prices and undervalued high-quality core assets are more attractive to funds.
QFII also focuses on the layout of relevant underlying stocks, such as Wanfu Bio, which was increased by 1.4452 million shares to 4.3499 million shares by the Abu Dhabi Investment Authority in the first quarter of this year. Wanfu Bio's main business is in vitro diagnostics, and its latest disclosure is that the related products are licensed by FDAEUA in the United States. The company's shares have rebounded steadily since late April and have risen more than 30% so far.
In addition, there are many companies with the key layout of QFII and obvious changes in stock prices since the second quarter, and a detailed list of individual stocks has been sorted out here, involving chemical industry, medicine, building materials, agriculture, forestry, animal husbandry and fishing, power equipment, machinery and equipment and other fields.
In addition to Wanfu biology, a number of other stocks that the Abu Dhabi Investment Authority increased its positions in the first quarter also ushered in a good rise, such as one of the pharmaceutical business targets, the company's share price has rebounded by 20% since the second quarter and reached a new high in nearly a year. The specific list and complete information can be obtained by scanning the QR code below [free].
(the mention of individual stocks in the article is only for example analysis and does not make trading recommendations. )
